Literature DB >> 2214615

Severe granulomatous giant cell myocarditis in Wegener's granulomatosis.

A Weidhase1, H J Gröne, C Unterberg, P Schuff-Werner, V Wiegand.   

Abstract

A 28-year-old male patient suffering from Wegener's granulomatosis died suddenly with signs of cardiac failure after clinical symptoms had basically subsided under chemotherapy. Autopsy revealed pulmonary granulomata, necrotizing vasculitis of the lungs and kidneys, focal and segmental necrotizing glomerulonephritis, and diffuse granulomatous and necrotizing giant cell myocarditis. Histological confirmation of inflammation of the heart in Wegener's disease has rarely been reported. Although cardiac involvement in Wegener's granulomatosis sometimes is suspected, it is usually thought to have no major impact on the course of the disease. By its dramatic clinical and morphologic presentation this case illustrates that the heart, in addition to the lungs and kidneys, may determine the outcome of the idiopathic granulomatous vasculitis of Wegener.

Entities:  

Mesh:

Year:  1990        PMID: 2214615     DOI: 10.1007/bf01662788

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

1.  Wegener's granulomatosis: pathology and review of the literature.

Authors:  G C GODMAN; J CHURG
Journal:  AMA Arch Pathol       Date:  1954-12

2.  Sudden and unexpected deaths of young soldiers; diseases responsible for such deaths during World War II.

Authors:  A R MORITZ; N ZAMCHECK
Journal:  Arch Pathol (Chic)       Date:  1946-11

3.  [Antibody against intra-cytoplasmic antigens: marker of Wegener's granulomatosis?].

Authors:  W L Gross; H Lehmann; A Beigel; A Duncker
Journal:  Dtsch Med Wochenschr       Date:  1986-09-26       Impact factor: 0.628

4.  Cardiac complications of Wegener granulomatosis: a case report of complete heart block and review of the literature.

Authors:  J Z Forstot; P A Overlie; G K Neufeld; C E Harmon; S L Forstot
Journal:  Semin Arthritis Rheum       Date:  1980-11       Impact factor: 5.532

5.  [Granulomas and granulomatoses. Cytobiologic and pathologic considerations].

Authors:  H Cain
Journal:  Pathologe       Date:  1981-03       Impact factor: 1.011

6.  Unusual cardiac complications of Wegener's granulomatosis.

Authors:  W A Schiavone; M Ahmad; S A Ockner
Journal:  Chest       Date:  1985-11       Impact factor: 9.410

7.  Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

Authors:  B Nölle; U Specks; J Lüdemann; M S Rohrbach; R A DeRemee; W L Gross
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

8.  Prolonged anuria and aortic insufficiency in a child with Wegener's granulomatosis.

Authors:  S Dabbagh; R L Chevalier; B C Sturgill
Journal:  Clin Nephrol       Date:  1982-03       Impact factor: 0.975

9.  Pathology of the heart and the cardiac conduction system in Wegener's granulomatosis.

Authors:  D C Allen; C C Doherty; D P O'Reilly
Journal:  Br Heart J       Date:  1984-12

Review 10.  [Vasculitis of the kidney].

Authors:  H J Gröne; M Osborn; W L Gross
Journal:  Verh Dtsch Ges Pathol       Date:  1989
View more
  5 in total

1.  Wegener's granulomatosis presenting as dilated cardiomyopathy.

Authors:  J D Day; K E Ellison; I Schnittger; M G Perlroth
Journal:  West J Med       Date:  1996 Jul-Aug

Review 2.  [Inflammatory cardiac diseases by primary extracardial diseases].

Authors:  M Brehm; P Rellecke; B E Strauer
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

Review 3.  Wegener's granulomatosis and the heart.

Authors:  S C Grant; R D Levy; M C Venning; C Ward; N H Brooks
Journal:  Br Heart J       Date:  1994-01

4.  Cardiac involvement in Wegener's granulomatosis.

Authors:  N E Goodfield; S Bhandari; W D Plant; A Morley-Davies; G R Sutherland
Journal:  Br Heart J       Date:  1995-02

5.  Unusual cardiac involvement in granulomatosis with polyangiitis manifesting as acute congestive heart failure.

Authors:  Htoo Kyaw; Deepika Misra; Malary M Mani; Won J Park; Meir Shinnar
Journal:  Anatol J Cardiol       Date:  2017-08       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.